Sjögren Syndrome

13 registered clinical trials studyying Sjögren Syndrome — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Terminated	Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye NCT06411132	Dompé Farmaceutici S.p.A	—
Recruiting	Dental and Periodontal Status of Patients With Sjögren's Syndrome. NCT04848870	Assistance Publique - Hôpitaux de Paris	—
Completed	Pelvic Floor Exercises in Patients With Sjögren's NCT05079581	Akdeniz University	N/A
Completed	Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome NCT04819269	Sylentis, S.A.	Phase 3
Completed	N-acetylcysteine for Primary Sjögren's Syndrome NCT04793646	University of Sao Paulo General Hospital	N/A
Completed	Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren' NCT03905525	Novartis Pharmaceuticals	Phase 2
Terminated	A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Sy NCT04035668	Novartis Pharmaceuticals	Phase 2
Completed	Comparison Between Rebamipide 2% Versus Autologous Serum NCT03608761	Hospital Nacional Profesor Alejandro Posadas	Phase 4
Completed	Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease NCT03762824	Region Skane	Phase 4
Completed	Early Detection of Pulmonary- and Pulmonary Vascular Disease in Sjögren Syndrome NCT02752269	Medical University of Graz	—
Completed	A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Synd NCT02011776	Santen Pharmaceutical(China) Co.,LTD	—
Completed	A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA NCT02049112	Unither Pharmaceuticals, France	Phase 4
Completed	Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity NCT03941184	Mayo Clinic	—